Editas Medicine, Inc.
ENGINEERED CAS9 NUCLEASES
Last updated:
Abstract:
The present disclosure relates to Cas9 nuclease variants and methods of producing and using such variants.
Status:
Application
Type:
Utility
Filling date:
14 Jul 2021
Issue date:
9 Jun 2022